Rotaviruses (RV) are the main cause of severe gastroenteritis in infants and are responsible for the death of approximately 600,000 young children annually around the world (54 and http://www.who.int/immunization monitoring/burden/rotavirus estimates/en/). At present, two live attenuated vaccines are licensed for use in humans, and both vaccines are highly protective against severe disease in developed countries (60,69). However, these oral vaccines induce lower levels of protection in children from developing countries, suggesting that the improvement of these vaccine or the development of new RV vaccines is warranted (32). Although the RV immune response has been extensively studied in both animals and humans, the immune factors that correlate with protection for natural infection or vaccination in people remain unclear, and this is an important obstacle for the development of the next generation of RV vaccines (2, 25).B cells play a critical role in the RV immune response, and both intestinal and systemic immunoglobulins (Ig) are associated with protection (25). For example, in the murine model, B-cell-but not T-cell-deficient mice are unable to establish long-lasting protective immunity against RV reinfection (26). The interaction of RV with B cells has been shown to be peculiar in many ways: the structural viral protein VP6 binds to an important fraction of human naive B cells via surface Ig (55, 58), and VP6 memory B cells (mBC) are enriched in the CD27 Ϫ IgG ϩ (58) and CD27 ϩ IgM ϩ subsets (66). VP6-specific naive B cells and, to a lesser extent, the mBC predominantly use the VH1-46 gene segment (66). Moreover, a massive Tcell-independent B cell activation and humoral response can be detected in vivo after oral RV infection in mice (10). However, the activation of these cells is probably viral strain dependent, since simian rhesus RV (RRV), but not bovine WC3 RV, has been shown to polyclonally stimulate a total antibodysecreting cell (ASC) response in intestinal organ fragment cultures (44). Although the principal immune function of B cells has been associated with the production of Ig, recent reports show that these cells also can play an important role in modulating the immune response independently of Ig through the production of cytokines like tumor necrosis factor alpha (TNF-␣), interleukin-6 (IL-6), and IL-10 and their related potential function as antigen-presenting cells (3,18,31,67).We and others have shown that RVs undergo systemic, extraintestinal replication in both immunodeficient and wild-type mice (16,24). In addition, a significant antigenemia and viremia is seen in most acutely infected children (8, 9). In particular, we have shown the in vivo replication of homologous and heterologous RV strains in B220 ϩ cells (a marker expressed by B cells or plasmacytoid dendritic cells [pDC]) obtained from murine mesenteric lymph node (24), and recently we also demonstrated that approximately 10% of primary human circulating B cells (CBC) are targets of RV infection in vitro (49).